Abstract:
A lytic reagent composition for measuring nucleated blood cells in a blood sample is described. The lytic reagent composition comprises a quaternary ammonium surfactant, an ethoxlyated phenol, and an ethoxylated alcohol. When mixed with a blood sample, the lytic reagent composition lyses red blood cells and enables a differentiation of nucleated red blood cells from other cell types by DC impedance measurement. The lytic reagent composition can further comprise an organic ligand for determining total hemoglobin concentration of a blood sample photometrically. Further disclosed is a lytic reagent system including the lytic reagent composition and a diluent. In addition, a single reagent composition containing salts is also disclosed, which can be used without a separate diluent. The lytic reagent compositions can be used for concurrent measurement of nucleated red blood cells, WBC, and hemoglobin of a blood sample.
Abstract:
A physically compact (saline) solution preparation apparatus includes a solution mixing tank (10) coupled to sources of concentrate and diluent. A concentrate transport path (16) is configured to both homogenize and deliver concentrate to the mixing tank, while the diluent transport path (12) is controllably purged of potential contaminates prior to supplying the diluent to the mixing tank. A mixed solution transport path (16) recirculates and thereby homogenizes the contents of the mixing container, and actively pumps out solution that has been mixed to a prescribed conductivity-based concentration, to one or more solution on demand storage reservoirs (24) for respective instruments. The operation of the apparatus is based upon measured conductivity of the contents of the solution mixing tank, so that there is no need to conduct precursor volumetric measurements of either diluent or concentrate.
Abstract:
The present invention provides a method for detecting myocardial necrosis by incubating a sample with a natural binding partner (troponin C) for troponin I and antibodies to troponin C and troponin I; and determining the resultant immune complex formed in proportion to the total concentration of troponin I in the sample.
Abstract:
This invention relates to a lytic reagent and a method of using the lytic reagent for automatically determining leukocyte subpopulations in blood. More specifically, the new lytic reagent lyses red blood cells and affects the eosinophils which enables the differentiation of at least one subpopulation of leukocytes. The lytic reagent is an acidic, hypertonic aqueous solution comprising an alkali metal salt of alkyl sulfate, an eosinolytic agent, a nonionic surfactant and a physiological salt. When used in combination with a second lytic reagent system, one is able to obtain at least a five part differential of leukocytes using DC and RF measurements.
Abstract:
A lytic reagent composition is provided which selectively stromatolyses red blood cells in a blood sample. In addition, a lytic reagent system is provided which enables the differentiation of at least three subpopulations of leukocytes. A method for using the lytic reagent system is also provided. Still further, the lytic reagent system finds use in the determination of the hemoglobin in the blood. The lytic reagent system utilizes an alkyl sulfate, polyoxyethylene-based surfactant and acid with a hypertonic, alkaline, stabilizing reagent. The system and analysis method maintains the cellular morphology of the leukocytes and can be used to analyze normal and abnormal blood samples, fresh and aged blood, human and non-human animal blood samples.
Abstract:
An apparatus (10) for measuring an analyte in a fluid sample (12) comprises a housing (H) defining a pair of chambers (26, 30) separated by a semipermeable membrane (28). The membrane allows the analyte of interest to pass between the chambers. The second chamber (30) contains a detector adapted to either (a) directly detect the analyte of interest or (b) to detect a reaction by product of the analyte upon reacting with a substance (14) such as an enzyme, introduced into the second chamber. Means are provided to flush the second chamber after each analyte measurement.
Abstract:
Blood cells of interest are readily distinguishable from other blood cells and look-a-like particles found in a blood sample by their back-scatter signature. A preferred method for differentiating platelets in a blood sample is to irradiate the cells and particles, one at a time, with a beam of radiation (B'), and to detect back-scattered (reflected) radiation (D') using a plurality of optical fibers (54) to transmit the back-scattered radiation (D') to a highgain photodetector (56), e.g. a photomultiplier tube. Preferably, the back scatter signal so obtained is combined with a second signal representing, for example, either the level of forward-scatter (FS) within a prescribed, relatively narrow angular range, or the level of side-scattered radiation (SS), or the level of attenuation of the cell-irradiating beam caused by the presence of the irradiated cell or particle in the beam, or the electrical impedance of the irradiated cell or particle, to differentiate the cells of interest. The method and apparatus of the invention are particularly useful in differentiating platelets and basophils in a blood sample.
Abstract:
A stabilization reagent composition, particularly desirable for stabilizing blood samples containing platelets, comprises reactants that generate multiple species of formaldehyde-ammonium complexes; at least one inhibitor of phosphatase enzymatic activity; and at least one inhibitor of protease enzymatic activity. Blood samples and other tissues are stabilized by this composition. Such stabilized samples are produced by methods for stabilizing the tissue by contacting the sample with the composition. Methods for assessing the efficacy of such stabilizing reagents are also included in this invention.
Abstract:
A method of analyzing nucleated red blood cells (NRBCs) in a blood sample and further enumerating NRBCs is disclosed. The method includes lysing a first aliquot and a second aliquot of a blood sample separately with a first lysing reagent system and a second lysing reagent system; measuring the first sample mixture in a flow cell by DC, RF, and light scatter measurements; measuring cell distributions and counting remaining blood cells in the second sample mixture by DC impedance measurements in a non-focused flow aperture; analyzing blood cell distribution patterns obtained from measuring the first sample mixture and from measuring the second sample mixture respectively; and further performing a combined analysis to differentiate NRBCs from other cell types and determine numbers of NRBCs in the blood sample.
Abstract:
A shear valve assembly comprises a pair of valve pads (10, 20) having opposing planar surfaces (21, 22) supported for relative sliding engagement. Each valve pad defines a plurality of liquid pathways by which a liquid can be passed from one pad to the other. The planar surface of one of the valve pads has an open channel formed therein, such channel having dimensions to accommodate a prescribed volume of liquid. Liquid is introduced into such channel via a first pair of pathways formed in the other valve pad, and liquid is dispensed from the open channel by a second pair of pathways that are brought into alignment with the channel during sliding movement between the valve pads. The valve assembly is particularly useful in blood analyzing instruments for isolating and dispensing relatively minute volumes (of the order of microliters) of whole blood for analysis.